// January In January, California sued insulin makers and PBMs over alleged price collusion. Oramed’s oral insulin failed in a phase 3 trial. TheracosBio’s Brenzavvy got FDA approval for diabetes. Eli Lilly invested $450 million in diabetes drug production. Claiming...